TIBOHCA: Safety, Tolerability and Pharmacokinetics of 2-Iminobiotin (2-IB) After OHCA

Clinical trial NCT02836340 · TERMINATED

Trial details

NCT number: NCT02836340
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cardiac Arrest Hypoxic Ischemic Brain Injury

Start date: 2016-05-01
Primary completion: 2019-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.